Correlative studies investigating effects of PI3K inhibition on peripheral leukocytes in metastatic breast cancer: potential implications for immunotherapy.
Carly Bess ScaliseCaroline A NebhanJinming YangLauren S StarnesChi YanAnna E VilgelmSheau-Chiann ChenGregory Dan AyersVandana AbramsonIngrid A MayerAnn RichmondPublished in: Breast cancer research and treatment (2020)
These results highlight the potential for PI3K inhibition to sensitize tumors to immune checkpoint inhibitors, thus providing additional therapeutic options for patients with MBC.